Delivery Order SPE2DB25D3012-SPE2DB25FXADW
- Not listed
- The Defense Logistics Agency awarded a $4,349.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Isosorbide Mononitrate 20 mg tablets (100 count) with a completion date of July 15, 2025. This non-set-aside contract represents a routine pharmaceutical procurement to support federal medical supply needs, likely for military or veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isosorbide Mononitrate 10 mg tablets (100 count) valued at $1,128.63. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Isosorbide Mononitrate 20 mg tablets (100-count bottles) under a firm fixed-price contract valued at $2,135.88. This non-competitive set-aside delivery order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a discrete purchase order issued under a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,423.92, is for the delivery of 4,568,171,219 units of Isosorbide Mononitrate 20 mg tablets in 100-count packages. The contract is a firm-fixed-price, non-set-aside award with a performance period ending on May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Isosorbide Mononitrate 120 mg tablets (100-count unit) with a ceiling value of $1,384.36. This is a firm fixed-price delivery order executed under a non-competitive set-aside arrangement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and...
- The Defense Logistics Agency awarded a $14,690.80 delivery order to AmerisourceBergen Drug Corp for the supply of Isosorbide Dinitrate 40 mg tablets (100-count units) with a firm fixed price contract structure. This non-set-aside award, effective September 16, 2025, with an ultimate completion date of September 17, 2025, supports federal pharmaceutical procurement needs with performance to occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,754,097 units of Isosorbide Dinitrate 40 mg tablets (100 per bottle). The contract has a completion date of February 26, 2024 and a potential value of $7,158.29. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a...
- This federal contract award, valued at $47,793.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of isosorbide dinitrate 40 mg tablets in 100-count bottles. The $13,462.47 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025. This single-award IDC...
- This federal contract award, valued at $3,479.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,722,938 units of Isosorbide Dinitrate 40 mg tablets, a drug used for the treatment of cardiovascular conditions. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXADWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,668.50 to AmerisourceBergen Drug Corp for the supply of Isosorbide Mononitrate 20 mg tablets (100 count) with a completion date of September 18, 2025. This is a firm fixed price, non-set-aside contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, where the company maintains operations as a major pharmaceutical distributor serving federal medical procurement needs. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 prime indefinite delivery vehicle (SPE2DX) with DLA Troop Support Medical running through December 2026, which serves as the contract authority for this and similar pharmaceutical delivery orders. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to military healthcare systems and other federal customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for the cardiovascular medication represents routine execution of that broader contract vehicle and reflects the company's role as a critical vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/17/25 |